Zoetis Inc ZTS

NYSE US Health Care Pharmaceuticals

$77.29 ▲ +1.66% (+$1.26)

Index member: S&P 500

⬆️ Above Yest. High 📅 Earnings This Week

Open $75.61

Prev Close $76.03

Day Range $74.91 – $77.52

52W Range $71.47 – $160.48

Market Cap $33.26B

P/E (TTM) 12.12

Beta 0.73

Div Yield 1.64%

EPS (TTM) $6.04

📋 Company Profile

Industry	Pharmaceuticals
Sector	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	2013-02-01
Shares Out.	419,230,000
Website	zoetis.com/ ↗
Phone	13026587581
Employees	14,500
Revenue	$2.26B
Gross Profit	$1.62B
Net Income	$601.0M
Free Cash Flow	$2.14B
Total Assets	$15.15B
Total Liabilities	$11.92B
Equity	$3.23B

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis Inc is a publicly traded company under the ticker symbol ZTS on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.